MedPath

ENTOCORT

ENTOCORT® EC (budesonide) CAPSULES

Approved
Approval ID

fe6530ef-1b23-451f-1290-0e3ef02ec1b5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jun 24, 2009

Manufacturers
FDA

Prometheus Laboratories Inc

DUNS: 967000860

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Budesonide

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code65483-702
Application NumberNDA021324
Product Classification
M
Marketing Category
C73594
G
Generic Name
Budesonide
Product Specifications
Route of AdministrationORAL
Effective DateJanuary 24, 2012
FDA Product Classification

INGREDIENTS (12)

METHACRYLIC ACIDInactive
Code: 1CS02G8656
Classification: IACT
BUDESONIDEActive
Quantity: 3 mg in 1 1
Code: Q3OKS62Q6X
Classification: ACTIB
ACETYLTRIBUTYL CITRATEInactive
Code: 0ZBX0N59RZ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
TRIETHYL CITRATEInactive
Code: 8Z96QXD6UM
Classification: IACT
FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
POLYSORBATE 80Inactive
Code: 6OZP39ZG8H
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
COLLOIDAL SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ENTOCORT - FDA Drug Approval Details